Etienne G C Brain

21PUBLICATIONS
152CO-AUTHORS
Liquid biopsiesPredictive and prognostic markersMolecular targetsRadiation therapyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (21)

|Apr 17, 2026
Transcriptomic Insights into Lobular Breast Cancer Biology and Patient Outcomes: Analysis of the MINDACT Clinical Trial.

|Sep 29, 2025
Prognostic Significance and Predictive Value of Circulating Tumor Cells in Invasive Lobular Breast Carcinoma-An Exploratory Analysis of the STIC CTC Trial.

Jose Luis Sandoval, Nicolas Kiavue, Lounes Djerroudi

|Sep 23, 2025
Combination of Olaparib, Durvalumab, and Fulvestrant in Patients with Advanced ER+/HER2- Breast Cancer and Selected Genomic Alterations: Results of the DOLAF Trial.

Séverine Guiu, Judith Balmaña, Pablo Lemercier

|Nov 03, 2024
Benefit of systemic therapy in MINDACT patients with small, ER-positive, HER2-negative breast cancers.

Florentine S Hilbers, Coralie Poncet, Konstantinos Tryfonidis

|Feb 27, 2024
Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis.

Antoine Vasseur, Luc Cabel, Caroline Hego

|Feb 01, 2024
Patient-Reported Outcomes in OlympiA: A Phase III, Randomized, Placebo-Controlled Trial of Adjuvant Olaparib in gBRCA1/2 Mutations and High-Risk Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer.

Patricia A Ganz, Hanna Bandos, Tanja Španić

Pageof 4

Frequent Collaborators

4 joint publications

Suzette Delaloge

4 joint publications

Anthony Goncalves

3 joint publications

Jean-Yves Pierga

3 joint publications

Thomas Bachelot